The incidence of personality disorder in adults with ADHD, and the effects on response to treatment with OROS methylphenidate (OROS MPH)

被引：0
|
作者：
Casciol, Carissa [1 ]
Sassoon, Rachel E. [2 ]
Carroll-Sharpe, Abigail [3 ]
Essick, Gregory K. [2 ]
Baranek, Grace T. [4 ]
机构：
[1] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA
[2] Univ N Carolina, Sch Dent, Ctr Neurosensory Disorders, Chapel Hill, NC USA
[3] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA
[4] Univ N Carolina, Dept Allied Hlth Sci, Chapel Hill, NC USA
来源：
BIOLOGICAL PSYCHIATRY | 2008年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
767
引用
收藏
页码：245S / 245S
页数：1
相关论文
共 50 条
  • [1] Assessing Personality Disorder in Adults With ADHD, and its Effects on Response to Treatment with OROS® Methylphenidate (OROS® MPH)
    Robison, Reid
    Reimherr, Frederick W.
    Marchant, Barrie K.
    Gale, Phillip
    Williams, Erika D.
    Strong, Robert E.
    Halls, Corinne
    Soni, Poonam
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 632 - 632
  • [2] The Impact of Age on Treatment Response With OROS® Methylphenidate (MPH) in Adults With ADHD
    Starr, Harriet L.
    Goodman, David W.
    Damaraju, Chandrasekhar Rao V.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 637 - 637
  • [3] Personality Disorder Assessment in Adult ADHD Utilizing Subjects Enrolled in a Clinical Trial of OROS® Methylphenidate (OROS® MPH)
    Williams, Erika
    Reimherr, Frederick W.
    Marchant, Barrie K.
    Strong, Robert E.
    Halls, Corinne
    Soni, Poonam
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 635 - 636
  • [4] Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate (OROS MPH)
    Marchant, Barrie K.
    Reimherr, Frederick W.
    Williams, Erika D.
    Strong, Robert E.
    Halls, Corinne
    Soni, Poonarn
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 246S - 246S
  • [5] Effects of OROS methylphenidate (OROS MPH) treatment in children and adolescents with ADHD, mental retardation and epilepsy
    Kesic, A.
    Lakic, A.
    Dronjak, D.
    Stupar, D.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S420 - S421
  • [6] Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD
    Robison, Reid J.
    Reimherr, Frederick W.
    Gale, Phillip D.
    Marchant, Barrie K.
    Williams, Erika D.
    Soni, Poonam
    Halls, Corinne
    Strong, Robert E.
    [J]. ANNALS OF CLINICAL PSYCHIATRY, 2010, 22 (02) : 94 - 102
  • [7] Treatment of adolescent ADHD with OROS® methylphenidate
    McBurnett, K
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 555A - 555A
  • [8] Predictors of treatment outcome in adults with ADHD treated with OROS® methylphenidate
    Buitelaar, Jan K.
    Kooij, J. J. Sandra
    Antoni Ramos-Quiroga, J.
    Dejonckheere, Joachim
    Casas, Miguel
    van Oene, Joop C.
    Schauble, Barbara
    Trott, Goetz-Erik
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02): : 554 - 560
  • [9] OROS MPH treatment effects between girls and boys with ADHD
    Starr, Harriette L.
    Zhang, Huabin
    Kemner, Jason E.
    Cooper, Kimberly M.
    [J]. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2006, 27 (05): : 442 - 442
  • [10] Effects of OROS® methylphenidate (MPH) treatment on behavior and performance in children with ADHD with and without comorbid learning disability
    Starr, H. Lynn
    Armstrong, Robert
    Damaraju, C., V
    Ascher, Steve
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (01) : S126 - S126
12345